Participant demographic and clinical characteristics.
Low-moderate fatigue
Severe fatigue
()
()
Mean ± SD or (%)
Mean ± SD or (%)
Age (years)
60.2 ± 16.8
50.4 ± 9.4
0.056
Male gender
9 (56.3)
7 (50.0)
0.732
Ethnicity
Hispanic/Latino
2 (12.5)
2 (14.3)
0.648
Non-Hispanic/Latino
14 (87.5)
12 (85.7)
Racial background
Non-Caucasian or Non-White
5 (31.3)
6 (42.3)
0.228
Caucasian or White
11 (68.7)
8 (57.7)
Marital status
Married or widowed
10 (62.5)
11 (78.6)
0.440
Single or divorced
6 (37.5)
3 (21.4)
Time since stroke (months)
43.7 ± 56.2
26.8 ± 28.8
0.323
Stroke side
Right
8 (50.0)
5 (35.7)
0.431
Left
8 (50.0)
9 (64.3)
Stroke type
Ischemic
13 (81.3)
7 (50.0)
0.122
Hemorrhagic
3 (18.7)
7 (50.0)
Stroke location
Supratentorial
15 (93.7)
12 (85.7)
0.586
Infratentorial
1 (6.3)
2 (14.3)
Stroke severity
mRS
2.6 ± 0.8
2.4 ± 0.7
0.359
BMI, kg/m2
27.3 ± 4.4
27.5 ± 5.3
0.935
Current smoker
2 (12.5)
2 (14.3)
0.648
Comorbidities
Hypertension
6 (37.5)
10 (71.4)
0.063
Diabetes
2 (12.5)
1 (7.1)
0.552
AF
2 (12.5)
0 (0.0)
0.485
CAD
2 (12.5)
0 (0.0)
0.485
Thyroid disease
0 (0.0)
0 (0.0)
—
Drug treatment
Immunosuppressant
0 (0.0)
0 (0.0)
Prednisolone
1 (6.3)
1 (7.1)
0.724
NSAIDs
0 (0)
2 (14.3)
0.209
Continuous variables are presented as mean ± standard deviation, whereas categorical variables are expressed as counts and percentages. mRS is modified Rankin Scale; BMI indicates body mass index; AF is atrial fibrillation; CAD is coronary artery disease; NSAIDs is nonsteroidal anti-inflammatories.
